Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13981710 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL3797056 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL1007043 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL1004929 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL16785948 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL4651473 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL9148547 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL21477447 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL21189542 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 | |
| SCHEMBL29051487 | 1.00 | TYR (0.74) | TYRPOLBATMEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101531691-A | Triazole glucoside, method for synthesizing same by enzyme chemical method and application thereof | SHANGHAI INST ORGANIC CHEM | 2009-09-16 | — | — | CN | claimed |
| US-6562209-B1 | Automated computer controlled reporter device for conducting imunnoassay and molecular biology procedures | NORTHROP GRUMMAN CORPORATION | 2003-05-13 | — | — | US | claimed |
| EP-0653438-A2 | Oligonucleotide compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-17 | — | — | EP | claimed |
| EP-0030964-A4 | NEGATIVE CONTROL MEDIA FOR MICROBIOLOGIC BIOCHEMICAL TESTS. | FLOW LAB (US) | 1981-11-11 | — | — | EP | claimed |
| EP-0030964-A1 | NEGATIVE CONTROL MEDIA FOR MICROBIOLOGIC BIOCHEMICAL TESTS. | FLOW LAB (US) | 1981-07-01 | — | — | EP | claimed |
| WO-1981000115-A1 | NEGATIVE CONTROL MEDIA FOR MICROBIOLOGIC BIOCHEMICAL TESTS | MINNESOTA MINING & MFG (US) | 1981-01-22 | — | — | WO | claimed |
| JP-6335395-A | — | — | None | — | — | JP | disclosed |
| WO-2025072098-A1 | INDUCIBLE EXPRESSION SYSTEMS | DNA TWOPOINTO INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| US-11773127-B2 | Compounds and methods for treating bacterial infections | WASHINGTON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| EP-3585792-B1 | RADIOLABELED BETA-GALACTOSIDASE SUBSTRATE FOR PET IMAGING OF SENESCENCE | UNIV TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-2970992-B1 | STERILIZATION INDICATOR INCLUDING A SIMPLIFIED GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER CO (US) | 2018-07-25 | — | — | EP | disclosed |
| CN-108042381-A | Paeonol derivative is in skin anti-inflammatory, anti-acne, whitening, nti-freckle and the application in dispelling pigmentation | 陕西医药控股医药研究院有限公司 | 2018-05-18 | — | — | CN | disclosed |
| EP-2970992-A1 | STERILIZATION INDICATOR INCLUDING A SIMPLIFIED GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | American Sterilizer Company (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-1989001040-A1 | ATTENUATED HERPES VIRUSES, HERPES VIRUSES WHICH INCLUDE FOREIGN DNA ENCODING AN AMINO ACID SEQUENCE AND VACCINES CONTAINING SAME | SYNTRO CORPORATION (US) | 1989-02-09 | — | — | WO | disclosed |
| EP-0299985-A1 | ENZYME CONTROLLED RELEASE SYSTEM. | POLAROID CORP (US) | 1989-01-25 | — | — | EP | disclosed |
| EP-0281927-A2 | Assay for nucleic acid sequences in a sample | Bayer Corporation (US) | 1988-09-14 | — | — | EP | disclosed |
| WO-1988005827-A1 | ENZYME CONTROLLED RELEASE SYSTEM AND ORGANIC CONJUGATE REACTANT | POLAROID CORPORATION (US) | 1988-08-11 | — | — | WO | disclosed |
| EP-0235726-A2 | Rapid detection of nucleic acid sequences in a sample by labeling the sample | MILES INC. (US) | 1987-09-09 | — | — | EP | disclosed |
| EP-0175560-A2 | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | disclosed |
| US-4444886-A | ENZYMATIC HYDROLYSIS | EASTMAN KODAK COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773127-B2 | Compounds and methods for treating bacterial infections | MMP8, ELANE, MPO | TYR 273/4885POLB 905/4885ATM 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.